Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA610337
Max Phase: Preclinical
Molecular Formula: C62H95N13O11
Molecular Weight: 1198.52
Molecule Type: Small molecule
Associated Items:
ID: ALA610337
Max Phase: Preclinical
Molecular Formula: C62H95N13O11
Molecular Weight: 1198.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)Nc1ccc(C[C@@H]2NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]3CCCN3C2=O)cc1
Standard InChI: InChI=1S/C62H95N13O11/c1-35(2)31-45-55(79)70-47(33-40-17-11-10-12-18-40)61(85)74-29-15-21-49(74)57(81)72-51(37(5)6)59(83)67-44(20-14-28-64)54(78)69-46(32-36(3)4)56(80)71-48(34-41-23-25-42(26-24-41)65-39(9)76)62(86)75-30-16-22-50(75)58(82)73-52(38(7)8)60(84)66-43(19-13-27-63)53(77)68-45/h10-12,17-18,23-26,35-38,43-52H,13-16,19-22,27-34,63-64H2,1-9H3,(H,65,76)(H,66,84)(H,67,83)(H,68,77)(H,69,78)(H,70,79)(H,71,80)(H,72,81)(H,73,82)/t43-,44-,45-,46-,47-,48-,49-,50-,51-,52-/m0/s1
Standard InChI Key: IOSUHWROHQGFTD-XVPUUEGOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1198.52 | Molecular Weight (Monoisotopic): 1197.7274 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. van der Knaap M, Engels E, Busscher HJ, Otero JM, Llamas-Saiz AL, van Raaij MJ, Mars-Groenendijk RH, Noort D, van der Marel GA, Overkleeft HS, Overhand M.. (2009) Synthesis and biological evaluation of asymmetric gramicidin S analogues containing modified D-phenylalanine residues., 17 (17): [PMID:19674904] [10.1016/j.bmc.2009.07.042] |
Source(1):